COO, Outlook Therapeutics
President, The Dagnon Group, LLC
Terry Dagnon is currently the chief operating officer (COO) of Outlook Therapeutics and president of the Dagnon Group, LLC. Terry began his career in the pharmaceutical industry as the regulatory affairs manager for Physician Reliance Network, Inc. (now known as U.S. Oncology) running the regulatory department of their oncology clinical research group. Terry continued his regulatory affairs career at Johnson & Johnson Medical, Inc. and had global regulatory responsibility for the wound care, skin care, and tissue engineering franchises. Terry was a senior vice president and general manager of one of the businesses units at Dohmen Life Science Services (DLSS) which was acquired and became EVERSANA. Prior to joining DLSS, Terry was the North America head of regulatory affairs at the Novartis Alcon division. Terry had a number of global and domestic roles of increasing responsibility at Alcon over a 13-year period. Terry’s regulatory experience has involved responsibility from research to post-market with a large number of domestic and global investigational and marketing approvals in the pharmaceutical, biologic and medical device space. Terry is also very experienced in compliance and working with R&D, marketing, sales, legal, manufacturing, quality, and supply chain organizations. Prior to a career in the medical industry, Terry served 11 years on active duty with the United States Army and was a SFC/E-7 18D Special Forces Green Beret Senior Non-Commissioned Officer. Terry and his wife, Carole, and their two sons reside in Colorado.